Columbus, OH, United States of America

Mark Fleming

This inventor holds 3 USPTO granted patents. Top assignee: Cytyc Corporation. Active years: 2003-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Fleming. Retrieved from https://idiyas.com/inventor/mark-fleming

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2003-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark Fleming: Innovator in Cytological Imaging

Introduction

Mark Fleming is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of cytological analysis, holding a total of 3 patents. His work focuses on enhancing the methods used for analyzing cytological materials, which has important implications in medical diagnostics.

Latest Patents

One of Mark Fleming's latest patents is a cytological imaging system and method. This invention pertains to the analysis of cytological material, specifically focusing on stains and methods for producing these stains. The invention includes methods for staining cells for cytological or histological analysis, allowing for a clear contrast between the nuclear and cytoplasmic portions of the cell. Additionally, the system provides methods for illuminating a cytological sample, with the analysis being capable of being automated or performed manually.

Career Highlights

Mark Fleming is currently associated with Cytyc Corporation, where he continues to innovate in the field of cytology. His work has been instrumental in advancing the techniques used in cytological imaging, contributing to better diagnostic tools in healthcare.

Collaborations

Some of his notable coworkers include David J Zahniser and Matthew S Zelinski. Their collaborative efforts have further enhanced the research and development of cytological imaging technologies.

Conclusion

Mark Fleming's contributions to cytological imaging represent a significant advancement in the field, showcasing his dedication to improving diagnostic methods. His innovative patents and collaborations continue to influence the landscape of medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…